rs104894675
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_203486.3(DLL3):c.712C>T(p.Arg238Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,612,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_203486.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLL3 | NM_203486.3 | c.712C>T | p.Arg238Ter | stop_gained | 5/9 | ENST00000356433.10 | NP_982353.1 | |
DLL3 | NM_016941.4 | c.712C>T | p.Arg238Ter | stop_gained | 5/8 | NP_058637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLL3 | ENST00000356433.10 | c.712C>T | p.Arg238Ter | stop_gained | 5/9 | 2 | NM_203486.3 | ENSP00000348810 | P1 | |
DLL3 | ENST00000205143.4 | c.712C>T | p.Arg238Ter | stop_gained | 5/8 | 1 | ENSP00000205143 | |||
DLL3 | ENST00000600437.1 | n.792C>T | non_coding_transcript_exon_variant | 5/6 | 1 | |||||
DLL3 | ENST00000596614.5 | c.410-2909C>T | intron_variant | 2 | ENSP00000471688 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 250346Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135520
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1460682Hom.: 0 Cov.: 35 AF XY: 0.00000963 AC XY: 7AN XY: 726744
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74358
ClinVar
Submissions by phenotype
Spondylocostal dysostosis 1, autosomal recessive Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2003 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | May 05, 2023 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 07, 2021 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Observed with a second DLL3 variant in an individual with spondylocostal dysostosis in the published literature (Bonafe et al., 2003); This variant is associated with the following publications: (PMID: 12791036, 23496422, 17213840, 25525159) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | This sequence change creates a premature translational stop signal (p.Arg238*) in the DLL3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DLL3 are known to be pathogenic (PMID: 12746394). This variant is present in population databases (rs104894675, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with spondylocostal dysostosis (PMID: 12791036). ClinVar contains an entry for this variant (Variation ID: 6833). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at